Literature DB >> 19632995

Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis.

Nadia F Lamour1, Preeti Subramanian, Dayanjan S Wijesinghe, Robert V Stahelin, Joseph V Bonventre, Charles E Chalfant.   

Abstract

Little is known about the regulation of eicosanoid synthesis proximal to the activation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha), the initial rate-limiting step. The current view is that cPLA(2)alpha associates with intracellular/phosphatidylcholine-rich membranes strictly via hydrophobic interactions in response to an increase of intracellular calcium. In opposition to this accepted mechanism of two decades, ceramide 1-phosphate (C1P) has been shown to increase the membrane association of cPLA(2)alpha in vitro via a novel site in the cationic beta-groove of the C2 domain (Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., and Chalfant, C. E. (2007) J. Biol. Chem. 282, 20467-204741). In this study we demonstrate that C1P is a proximal and required bioactive lipid for the translocation of cPLA(2)alpha to intracellular membranes in response to inflammatory agonists (e.g. calcium ionophore and ATP). Last, the absolute requirement of the C1P/cPLA(2)alpha interaction was demonstrated for the production of eicosanoids using murine embryonic fibroblasts (cPLA(2)alpha(-/-)) coupled to "rescue" studies. Therefore, this study provides a paradigm shift in how cPLA(2)alpha is activated during inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632995      PMCID: PMC2785377          DOI: 10.1074/jbc.M109.001677

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Properties and regulation of cytosolic phospholipase A2.

Authors:  C C Leslie
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

Review 2.  Cytosolic phospholipase A2.

Authors:  J D Clark; A R Schievella; E A Nalefski; L L Lin
Journal:  J Lipid Mediat Cell Signal       Date:  1995-10

3.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Authors:  T Hida; Y Yatabe; H Achiwa; H Muramatsu; K Kozaki; S Nakamura; M Ogawa; T Mitsudomi; T Sugiura; T Takahashi
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

Review 4.  Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2).

Authors:  R M Kramer; J D Sharp
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

5.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

Authors:  P J Jakobsson; S Thorén; R Morgenstern; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Expression of cyclooxygenase-2 in human lung carcinoma.

Authors:  H Wolff; K Saukkonen; S Anttila; A Karjalainen; H Vainio; A Ristimäki
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

7.  Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2.

Authors:  L J Reynolds; L L Hughes; A I Louis; R M Kramer; E A Dennis
Journal:  Biochim Biophys Acta       Date:  1993-04-23

8.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect.

Authors:  W Kutchera; D A Jones; N Matsunami; J Groden; T M McIntyre; G A Zimmerman; R L White; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  Sphingolipids in atherosclerosis and vascular biology.

Authors:  S Chatterjee
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

10.  Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers.

Authors:  A Tay; J S Simon; J Squire; K Hamel; H J Jacob; K Skorecki
Journal:  Genomics       Date:  1995-03-01       Impact factor: 5.736

View more
  42 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

3.  Exogenous ceramide-1-phosphate reduces lipopolysaccharide (LPS)-mediated cytokine expression.

Authors:  Jody L Hankins; Todd E Fox; Brian M Barth; Kellee A Unrath; Mark Kester
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.

Authors:  Sophia Karandashova; Apparao Kummarapurugu; Shuo Zheng; Le Kang; Shumei Sun; Bruce K Rubin; Judith A Voynow
Journal:  Pediatr Pulmonol       Date:  2018-04-06

5.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

6.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

7.  JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2.

Authors:  Albert Gubern; Miquel Barceló-Torns; David Barneda; José M López; Roser Masgrau; Fernando Picatoste; Charles E Chalfant; Jesús Balsinde; María A Balboa; Enrique Claro
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

Review 8.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

Review 9.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

10.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.